Atos Lifesciences Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glimitos MV Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimitos MV Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimitos MV Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimitos MV Tablet.
Glimitos MV Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimitos MV Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimitos MV Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimitos MV Tablet contains a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used to treat type 2 diabetes mellitus (DM). It helps to improve blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride reduces blood glucose by increasing the release of insulin from the pancreas. Metformin lowers glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not indicated for Type 1 DM treatment.
Possible side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection. These may occur in some individuals but it is not a comprehensive list.
Glimitos MV Tablet should not be used if the patient has known allergies to any of its components or excipients. It is also not recommended for individuals with moderate to severe kidney disease and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
No, Glimitos MV Tablet should not be taken with alcohol. It may lower your blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Yes, using Glimitos MV Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. It is more likely to occur if you miss or delay meals, drink alcohol excessively, over-exercise, or take other antidiabetic medications with it. Regular monitoring of blood sugar levels is essential. Always have glucose tablets, honey, or fruit juice available.
Store the medicine in its original packaging, tightly sealed. Store it according to the instructions on the label. Do not use expired medication. Discard unused medicine responsibly, ensuring pets, children, and other individuals do not have access to it.